Journal of Diabetes Research

Pathogenesis, Diagnosis, and Treatment of Diabetic Retinopathy


Publishing date
01 Aug 2019
Status
Closed
Submission deadline
15 Mar 2019

Lead Editor

1Vall d’Hebron Rsearch Institute (VHIR), Barcelona, Spain

2Queen’s University, Belfast, UK

3University Hospital Maggiore della Carita, Novara, Italy

This issue is now closed for submissions.
More articles will be published in the near future.

Pathogenesis, Diagnosis, and Treatment of Diabetic Retinopathy

This issue is now closed for submissions.
More articles will be published in the near future.

Description

Diabetic retinopathy (DR) is a common complication of diabetes and remains a main cause of blindness among working-age individuals in developed countries. The concept of DR as a microvascular disease has evolved into that of a more complex diabetic complication in which neurodegeneration and inflammation play a significant role. Apart from being a devastating complication of diabetes, DR is a sentinel of other chronic diabetic complications.

This special issue welcomes the submission of original research articles focusing on new mechanisms involved in the pathogenesis of early stages of DR, as well as new methods of screening and diagnostic imaging. Contributions highlighting a link between DR and other diabetic complications as well as papers showing new data regarding novel therapeutic strategies are highly encouraged. Finally, comprehensive reviews on these items will also be welcome.

Potential topics include but are not limited to the following:

  • The role of neurodegeneration and the neurovascular unit in the pathogenesis of DR
  • Inflammation and oxidative stress: new perspectives in the development of DR
  • New imaging and deep learning techniques for the screening and diagnosis of DR
  • Updated methods for in vivo metabolic assessment of the diabetic retina
  • The relationship between DR and other diabetic complications
  • DR as a window to the brain: the role of retinal assessment for identifying diabetic patients at risk of developing neurodegenerative diseases
  • New treatments of DR based on neuroprotection, anti-inflammation, or antioxidative stress
  • Diabetic medication and its potential effect on DR
Journal of Diabetes Research
 Journal metrics
Acceptance rate34%
Submission to final decision85 days
Acceptance to publication27 days
CiteScore3.020
Impact Factor3.040
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.